Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
Feature|Articles|June 10, 2025
New COVID-19 Vaccine Recommendations Cause Confusion Among Public, Health Care Providers
Author(s)Ashley Gallagher, MA
Fact checked by: Killian Meara
The conflicting information and abrupt changes are likely to contribute to a lack of trust and confidence in health care, Lauren Angelo, PharmD, MBA, said.
Advertisement
Advertisement
Within the past few weeks, there has been a lot of information coming out about the COVID-19 vaccine and the upcoming 2025-2026 respiratory season. Recommendations, which were once aligned, have now become conflicting—the Department of Health and Human Services (HHS) has one set and the CDC website has another.
Related to this article
A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.
Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
Advertisement
Advertisement